6505--Pioglitazone Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0030
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its NAC Pharmaceuticals office, has issued an award notice for the procurement of Pioglitazone Tablets. This initiative falls under the NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is classified with the product service code 6505, indicating a focus on pharmaceutical products. The procurement identifier for this activity is 36E79726R0030.
The primary purpose of this procurement is to secure a reliable supply of Pioglitazone Tablets, a medication commonly used in the management of diabetes, for distribution within the VA healthcare system. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Pioglitazone Tablets, ensuring that the VA can meet the ongoing needs of its patient population. The intended outcome is to maintain consistent access to high-quality medications, supporting the health and well-being of veterans under VA care.
Key requirements for this contract include adherence to stringent pharmaceutical manufacturing standards, as outlined in the NAICS 325412 classification. Contractors are expected to deliver Pioglitazone Tablets that meet all applicable regulatory and quality specifications, ensuring safety and efficacy for end users. The deliverables will primarily consist of the specified medication, provided in quantities and packaging formats as determined by the VA’s operational requirements.
The contracting entity responsible for this procurement is NAC Pharmaceuticals, a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is Michael Olszewski, who can be reached via email at [email protected] or by phone at 708-786-4966. Contractors seeking further information or clarification are encouraged to utilize these contact details.
This procurement is an award notice, indicating that the contract has already been issued and is currently active. The notice was posted on December 11, 2026, and remains accessible through the SAM.gov portal, with additional documentation available via the provided URL. There are no explicit set-aside requirements or special considerations detailed in the notice, and the procurement type is not specified beyond its award status.
Contractors evaluating this opportunity should note that the core elements—manufacturing and supply of Pioglitazone Tablets, compliance with pharmaceutical standards, and ongoing support for VA healthcare operations—will remain constant throughout the contract lifecycle. The VA’s commitment to quality and reliability underscores the importance of partnering with manufacturers capable of meeting rigorous federal requirements.
For further details, interested parties can review the notice and its attachments on SAM.gov using Opportunity ID 6da9f5238f0b48a7829110badda218da.